4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$6.60 USD
-0.50 (-7.04%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $6.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
4D Molecular Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FDMT 6.60 -0.50(-7.04%)
Will FDMT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FDMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FDMT
SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Misses Revenue Estimates
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Misses Revenue Estimates
Other News for FDMT
Is FDMT preparing to trend lower? Fell Below 20 Day Moving Average shows up after crashing 7.04%
H.C. Wainwright Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)
Crossed Above 20 Day Moving Average appears for FDMT after 6.61% move
FDMT forms 20 Day Moving Average Resistance on September 17
FDMT forms 1,2,3 Pullback Bullish on September 16